Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AMG 510
AMG 510
Amgen publishes, presents data on therapy with ‘undruggable’ target
MedCity News
Mon, 09/21/20 - 10:33 am
Amgen
sotorasib
ESMO
AMG 510
non-small cell lung cancer
Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug
Fierce Biotech
Tue, 03/31/20 - 10:54 am
Amgen
KRAS
AMG 510
COVID-19
clinical trials
cancer
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More
Xconomy
Mon, 09/9/19 - 08:08 pm
WCLC
lung cancer
KRAS
AMG 510
Amgen
RET
Merck
Keytruda
AstraZeneca
Imfinzi
Blueprint Medicines
Eli Lilly
What could help biotech close out 2019 stronger? Analysts pick 3 events to watch
Biopharma Dive
Sat, 09/7/19 - 06:38 pm
Amgen
AMG 510
KRAS inhibitors
Roche
PTC Therapeutics
risdiplam
Eylea
Novartis
4 Biotech Stocks With Big Catalysts in September
Motley Fool
Thu, 09/5/19 - 10:14 pm
Amgen
AMG 510
Mirati Therapeutics
MRTX849
Eli Lilly
LOXO-292
Blueprint Me
Pralsetinibdicines
Amgen’s ‘White Whale’ Cancer Data May Send Shares to Record High
Bloomberg
Wed, 09/4/19 - 10:20 am
Amgen
AMG 510
colon cancer
non-small cell lung cancer
3 Cancer Stocks Given a Lift by Amgen
Motley Fool
Tue, 06/4/19 - 11:07 am
Amgen
KRAS
AMG 510
Mirati Therapeutics
Array Biopharma
Gilead Sciences
ASCO 2019
Did This Biotech Giant Just Find The Key To An 'Undruggable' Protein?
Investors Business Daily
Mon, 06/3/19 - 11:37 pm
Amgen
AMG 510
KRAS
ASCO 2019
lung cancer
colon cancer
Early cancer drug data give Amgen hope it's 'cracked KRAS code'
Biopharma Dive
Mon, 06/3/19 - 11:30 am
ASCO 2019
KRAS
lung cancer
colorectal cancer
pancreatic cancer
Amgen
AMG 510
Here's Why Mirati Therapeutics Is Surging Today
Motley Fool
Thu, 05/16/19 - 06:42 pm
Mirati Therapeutics
Amgen
KRAS inhibitors
MRTX849
AMG 510